Evaluation and management of the febrile child in the conjugated vaccine era.
Akintemi
Olakunle B
OB
Pediatric Teaching Program, Moses Cone Health System, 1200 North Elm Street, Greensboro, NC 27401, USA. Ola.Akintemi@mosescone.com
Roberts
Kenneth B
KB
D000900:Anti-Bacterial Agents; D016470:Bacteremia / Q000453:epidemiology / Q000382:microbiology; D002443:Ceftriaxone / Q000008:administration & dosage / Q000627:therapeutic use; D002675:Child, Preschool; D005334:Fever / Q000209:etiology* / Q000382:microbiology / Q000628:therapy*; D006192:Haemophilus Infections / Q000517:prevention & control; D018073:Haemophilus Vaccines; D006193:Haemophilus influenzae; D006801:Humans; D007223:Infant; D011008:Pneumococcal Infections / Q000517:prevention & control; D022242:Pneumococcal Vaccines; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D014552:Urinary Tract Infections / Q000175:diagnosis; D018074:Vaccines, Conjugate
D000900:Anti-Bacterial Agents; D018073:Haemophilus Vaccines; D022242:Pneumococcal Vaccines; D018074:Vaccines, Conjugate; D002443:Ceftriaxone